ERa36 Modulator Icaritin

A metabolite of icariin, a principal flavonoid glycoside in Herba Epimedii (a traditional Chinese medicine herb used in treating osteoporosis) with potential antineoplastic activity. ERa36 modulator icaritin selectively binds to a novel variant of estrogen receptor alpha, a36, and mediates a membrane-initiated "nongenomic" signaling pathway, which is linked to activate signaling pathways like the MAPK/ERK and the PI3K/Akt pathways. This agent induces cell cycle arrest at G1, or G2/M arrest depending upon the dose. Consistently with G1 arrest, icaritin increases protein expressions of pRb, p27(Kip1) and p16(Ink4a), while decreasing phosphorylated pRb, Cyclin D1 and CDK4. 40% of ER-negative breast cancer tumors express high levels of ERa36, and this subset of patients is less likely to benefit from tamoxifen treatment compared with those with ERa66-positive/ERa36-negative tumors. (NCI Thesaurus)

YOU MAY ALSO LIKE

ERA-923

A substance that is being studied as a treatment for cancer. It belongs to a family of drugs called antiestrogens.

ER+

Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are ER+ may need estrogen to grow,…

ER-negative PR-negative HER2/neu-negative breast cancer

Describes breast cancer cells that do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein. Also called triple-negative breast…

ER-

Describes cells that do not have a protein to which the hormone estrogen will bind. Cancer cells that are ER- do not…

ER

A protein found inside the cells of the female reproductive tissue, some other types of tissue, and some cancer cells. The hormone…

Equivocal

Open to question.